Multi-locus variable number of tandem repeat analysis for rapid and accurate typing of virulent multidrug resistant Escherichia coli clones

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Naseer, Umaer ^a,f   Olsson Liljequist, Barbro E ^b   Woodford, Neil ^c   Dhanji, Hiran ^c   Cantón, Rafael ^d,e   Sundsfjord, Arnfinn ^a,f   Lindstedt, Bjørn Arne ^g  

^a UNIVERSITY OF TROMSØ   (Norway)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e CSIC   (Spain)

^f UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^g NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ENZYME; BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE CMY; BETA LACTAMASE CTX M; BETA LACTAMASE SHV; UNCLASSIFIED DRUG;

ACCURACY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; ESCHERICHIA COLI; GENE CLUSTER; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; MOLECULAR CLONING; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; MULTILOCUS VARIABLE NUMBER OF TANDEM REPEAT ANALYSIS; NONHUMAN; NORWAY; PLASMID; SEQUENCE ANALYSIS; SPAIN; STRAIN DIFFERENCE; SWEDEN; TANDEM REPEAT;

BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GREAT BRITAIN; MINISATELLITE REPEATS; MULTILOCUS SEQUENCE TYPING; NORWAY; SPAIN; SWEDEN;

ESCHERICHIA COLI;

EID: 84864412176     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041232     Document Type: Article

References (30)

1. Woodford N, Wareham DW,((2009)) Tackling antibiotic resistance: a dose of common antisense? J Antimicrob Chemother 63:: 225--229.
2. Woodford N, Turton JF, Livermore DM,((2011)) Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 35:: 736--755.
3. Canton R, Morosini MI,((2011)) Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol Rev 35:: 977--991.
4. Barbosa TM, Levy SB,((2000)) The impact of antibiotic use on resistance development and persistence. Drug Resist Updat 3:: 303--311.
5. Pitout JD, Campbell L, Church DL, Gregson DB, Laupland KB,((2009)) Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region. Antimicrob Agents Chemother 53:: 2539--2543.
6. Oteo J, Perez-Vazquez M, Campos J,((2010)) Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 23:: 320--326.
7. Pitout JD,((2010)) Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70:: 313--333.
8. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, et al.((2007)) CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 59:: 165--174.
9. Canton R, Coque TM,((2006)) The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 9:: 466--475.
10. Castanheira M, Mendes RE, Rhomberg PR, Jones RN,((2008)) Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. Medical Centers: molecular evaluation from the MYSTIC Program (2007). Microb Drug Resist 14:: 211--216.
11. Canton R, Ruiz-Garbajosa P,((2011)) Co-resistance: an opportunity for the bacteria and resistance genes. Curr Opin Pharmacol 11:: 477--485.
12. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, et al.((2008)) Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 14:: 195--200.
13. Naseer U, Sundsfjord A,((2011)) The CTX-M Conundrum: Dissemination of Plasmids and Escherichia coli Clones. Microb Drug Resist.
14. Wirth T, Falush D, Lan R, Colles F, Mensa P, et al.((2006)) Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 60:: 1136--1151.
15. Lau SH, Cheesborough J, Kaufmann ME, Woodford N, Dodgson AR, et al.((2010)) Rapid identification of uropathogenic Escherichia coli of the O25:H4-ST131 clonal lineage using the DiversiLab repetitive sequence-based PCR system. Clin Microbiol Infect 16:: 232--237.
16. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, et al.((2009)) Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 53:: 2733--2739.
17. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, et al.((2009)) Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 64:: 274--277.
18. Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, et al.((2009)) Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 63:: 1135--1141.
19. Lindstedt BA,((2005)) Multiple-locus variable number tandem repeats analysis for genetic fingerprinting of pathogenic bacteria. Electrophoresis 26:: 2567--2582.
20. Lindstedt BA, Brandal LT, Aas L, Vardund T, Kapperud G,((2007)) Study of polymorphic variable-number of tandem repeats loci in the ECOR collection and in a set of pathogenic Escherichia coli and Shigella isolates for use in a genotyping assay. J Microbiol Methods 69:: 197--205.
21. Lobersli I, Haugum K, Lindstedt BA,((2012)) Rapid and high resolution genotyping of all Escherichia coli serotypes using 10 genomic repeat-containing loci. J Microbiol Methods 88:: 134--139.
22. Morosini MI, Garcia-Castillo M, Coque TM, Valverde A, Novais A, et al.((2006)) Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline. Antimicrob Agents Chemother 50:: 2695--2699.
23. Rogers BA, Sidjabat HE, Paterson DL,((2011)) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66:: 1--14.
24. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, et al.((2008)) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61:: 273--281.
25. Johnson JR, Miller S, Johnston B, Clabots C, Debroy C,((2009)) Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and Urovirulent E. coli strains among dogs and cats within a household. J Clin Microbiol 47:: 3721--3725.
26. Morris D, Boyle F, Ludden C, Condon I, Hale J, et al.((2011)) Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone. Antimicrob Agents Chemother 55:: 4935--4936.
27. Peirano G, Schreckenberger PC, Pitout JD,((2011)) Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131. Antimicrob Agents Chemother 55:: 2986--2988.
28. Geue L, Schares S, Mintel B, Conraths FJ, Muller E, et al.((2010)) Rapid microarray-based genotyping of enterohemorrhagic Escherichia coli serotype O156:H25/H-/Hnt isolates from cattle and clonal relationship analysis. Appl Environ Microbiol 76:: 5510--5519.
29. Monecke S, Mariani-Kurkdjian P, Bingen E, Weill FX, Baliere C, et al.((2011)) Presence of enterohemorrhagic Escherichia coli ST678/O104:H4 in France prior to 2011. Appl Environ Microbiol 77:: 8784--8786.
30. Karger A, Ziller M, Bettin B, Mintel B, Schares S, et al.((2011)) Determination of serotypes of Shiga toxin-producing Escherichia coli isolates by intact cell matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl Environ Microbiol 77:: 896--905.